The need for speed

green light new law approval
Is the push for faster regulatory approval of new drugs a benefit to patients or a safety risk? The increasing pressure from patients, pharmaceutical companies and sometimes, health professionals, eager to access new medications, needs to be handled cautiously, perhaps via new approval categories, an expert believes.  In an editorial in Australian Prescriber, Paul Kubler,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Peering into the AJP crystal ball
Next Clinical tips: family health